FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2241130671> ?p ?o ?g. }

• W2241130671 abstract "Abstract Introduction Allogeneic hematopoietic cell transplantation (allo-HCT) provides long-term immunologic disease control for a substantial portion of patients with hematologic malignancies. Chronic lymphocytic leukemia (CLL) is sensitive to graft-versus-leukemia (GVL) effects as evidenced by responses to reduced-intensity conditioning (RIC) allo-HCT, and to donor lymphocyte infusions (DLI) for post-HCT relapse. To identify potential alloreactive (AR)/GVL T cells, we performed in vitro mixed lymphocyte reactions (MLRs) between recipient CLL cells and donor T cells derived from blood apheresis products acquired for DLI. Responder and non-responder T cell populations from MLRs and recipient post-HCT blood samples underwent T cell receptor beta (TCRB) high-throughput sequencing (HTS). The prevalence of candidate AR/GVL TCRB clonotypes at various times following HCT was quantified and correlated with CLL disease burden and graft-versus-host disease (GVHD). Methods CLL cells isolated from cryopreserved PBMC aliquots of 7 patients who experienced post-HCT relapse were pre-stimulated in vitro for 72 hours with CpG oligodeoxynucleotides in X-VIVO 15 supplemented with IL-4, IL-7, BAFF, and GM-CSF. Upregulation of CD80, CD86, CD40L, MHCI, and/or MHCII was confirmed by flow cytometry. Donor T cells were isolated from cryopreserved DLI using pan-T cell isolation beads (Miltenyi), labeled with CFSE, and incubated with CpG-stimulated CLL cells for 7 days. Upon the conclusion of the MLR incubation, T cell populations were sorted into rapid responders (RR; CFSEdim), slow responders (SR; CFSEbrightCD69pos) and non-responders (NR; CFSEbrightCD69neg) and RNA was isolated from each cell population. RNA was then amplified and TCRB sequenced using the LymphoSIGHT platform (Sequenta). PBMC samples collected and cryopreserved pre-HCT and regularly following HCT and DLI were also subjected to TCRB-HTS. Results RR cells comprised 11.5 +/- 9.2% of MLR T cells, whereas SR were 4.2 +/- 3.5% and NR were 84.3 +/- 10.1% (Fig 1A). RR, SR, and NR populations demonstrated clonotypic exclusion with a mean 4.4% +/- 5.5% coincidence between populations (Fig 1B). TCRB diversity in the RR population was more restricted compared with diversity in the SR and NR populations, with the mean number of clonotypes comprising the top 50th percentile of total TCRB reads being 11.8 +/- 6.5%, 17.7 +/- 8.5%, and 20.2 +/- 1.8% of unique reads, respectively (p<0.01). Candidate AR/GVL TCRB clonotypes, specified as those enriched in MLR-responder populations compared to pre-stimulation samples, were validated by comparison with pre-stimulation frequency-matched clonotypes. The mean frequency of AR/GVL TCRB clonotypes in blood samples post-HCT were 10- to 100-fold greater than control clonotypes, depending on the patient (Fig 1C). AR/GVL T cells were present within the post-HCT PBMC TCRB repertoires at mean frequencies of 5x10-4 at day +90 rising to 2x10-3 by day +360 post-HCT in 3/4 patients experiencing at least 2 year remissions post-HCT. In patients experiencing early relapse (within 1yr post-HCT), no candidate AR/GVL clonotypes were identified in 1/3 patients and 2/3 exhibited AR/GVL clonotypes at roughly one log lower frequencies (mean 8x10-5 at day +90 and 4x10-4 at day 360) than those with longer remissions (Fig 1D). One patient who experienced fatal post-DLI steroid-refractory GVHD exhibited striking changes in AR/GVL clonotype prevalence following DLI (Fig 1D). Conclusions In vitro MLR between donor T cells and CpG-stimulated CLL cells selects clonotypically distinct T cell populations with an oligoclonal RR population. Persistence of adoptively transferred candidate AR/GVL clones identified by MLR appears to correlate with likelihood of maintaining clinical remission beyond 2 years in CLL patients undergoing RIC allo-HCT. Failure to adoptively transfer AR/GVL clonotypes may be associated with early treatment failure. Disclosures: Klinger: Sequenta, Inc.: Employment, Research Funding. Moorhead:Sequenta, Inc.: Employment, Research Funding. Zheng:Sequenta, Inc.: Employment, Research Funding. Faham:Sequenta Inc.: Employment, Stockholder Other." @default.
• W2241130671 created "2016-06-24" @default.
• W2241130671 creator A5002571777 @default.
• W2241130671 creator A5014518933 @default.
• W2241130671 creator A5022565348 @default.
• W2241130671 creator A5045057234 @default.
• W2241130671 creator A5046180673 @default.
• W2241130671 creator A5054118827 @default.
• W2241130671 creator A5077947210 @default.
• W2241130671 creator A5081926380 @default.
• W2241130671 date "2013-11-15" @default.
• W2241130671 modified "2023-10-01" @default.
• W2241130671 title "Alloreactive T Cell Clonotypes Identified By In Vitro Mixed Lymphoid Reaction and High-Throughput Sequencing Exhibit Increased Frequency In Peripheral Blood Samples From Patients Following Allogeneic Hematopoietic Cell Transplantation For Chronic Lymphocytic Leukemia" @default.
• W2241130671 doi "https://doi.org/10.1182/blood.v122.21.149.149" @default.
• W2241130671 hasPublicationYear "2013" @default.
• W2241130671 type Work @default.
• W2241130671 sameAs 2241130671 @default.
• W2241130671 citedByCount "0" @default.
• W2241130671 crossrefType "journal-article" @default.
• W2241130671 hasAuthorship W2241130671A5002571777 @default.
• W2241130671 hasAuthorship W2241130671A5014518933 @default.
• W2241130671 hasAuthorship W2241130671A5022565348 @default.
• W2241130671 hasAuthorship W2241130671A5045057234 @default.
• W2241130671 hasAuthorship W2241130671A5046180673 @default.
• W2241130671 hasAuthorship W2241130671A5054118827 @default.
• W2241130671 hasAuthorship W2241130671A5077947210 @default.
• W2241130671 hasAuthorship W2241130671A5081926380 @default.
• W2241130671 hasConcept C126322002 @default.
• W2241130671 hasConcept C154317977 @default.
• W2241130671 hasConcept C202751555 @default.
• W2241130671 hasConcept C203014093 @default.
• W2241130671 hasConcept C2776090121 @default.
• W2241130671 hasConcept C2777761686 @default.
• W2241130671 hasConcept C2777938653 @default.
• W2241130671 hasConcept C2778297628 @default.
• W2241130671 hasConcept C2778461978 @default.
• W2241130671 hasConcept C2779695342 @default.
• W2241130671 hasConcept C2779972918 @default.
• W2241130671 hasConcept C2781101188 @default.
• W2241130671 hasConcept C2908647359 @default.
• W2241130671 hasConcept C2911091166 @default.
• W2241130671 hasConcept C39347974 @default.
• W2241130671 hasConcept C55493867 @default.
• W2241130671 hasConcept C71924100 @default.
• W2241130671 hasConcept C86803240 @default.
• W2241130671 hasConcept C8891405 @default.
• W2241130671 hasConcept C99454951 @default.
• W2241130671 hasConceptScore W2241130671C126322002 @default.
• W2241130671 hasConceptScore W2241130671C154317977 @default.
• W2241130671 hasConceptScore W2241130671C202751555 @default.
• W2241130671 hasConceptScore W2241130671C203014093 @default.
• W2241130671 hasConceptScore W2241130671C2776090121 @default.
• W2241130671 hasConceptScore W2241130671C2777761686 @default.
• W2241130671 hasConceptScore W2241130671C2777938653 @default.
• W2241130671 hasConceptScore W2241130671C2778297628 @default.
• W2241130671 hasConceptScore W2241130671C2778461978 @default.
• W2241130671 hasConceptScore W2241130671C2779695342 @default.
• W2241130671 hasConceptScore W2241130671C2779972918 @default.
• W2241130671 hasConceptScore W2241130671C2781101188 @default.
• W2241130671 hasConceptScore W2241130671C2908647359 @default.
• W2241130671 hasConceptScore W2241130671C2911091166 @default.
• W2241130671 hasConceptScore W2241130671C39347974 @default.
• W2241130671 hasConceptScore W2241130671C55493867 @default.
• W2241130671 hasConceptScore W2241130671C71924100 @default.
• W2241130671 hasConceptScore W2241130671C86803240 @default.
• W2241130671 hasConceptScore W2241130671C8891405 @default.
• W2241130671 hasConceptScore W2241130671C99454951 @default.
• W2241130671 hasLocation W22411306711 @default.
• W2241130671 hasOpenAccess W2241130671 @default.
• W2241130671 hasPrimaryLocation W22411306711 @default.
• W2241130671 hasRelatedWork W1966313006 @default.
• W2241130671 hasRelatedWork W2036608919 @default.
• W2241130671 hasRelatedWork W2075333334 @default.
• W2241130671 hasRelatedWork W2188177124 @default.
• W2241130671 hasRelatedWork W2411515677 @default.
• W2241130671 hasRelatedWork W2412629605 @default.
• W2241130671 hasRelatedWork W2547706312 @default.
• W2241130671 hasRelatedWork W2554001851 @default.
• W2241130671 hasRelatedWork W2565048265 @default.
• W2241130671 hasRelatedWork W2566327995 @default.
• W2241130671 hasRelatedWork W2587045623 @default.
• W2241130671 hasRelatedWork W2611736491 @default.
• W2241130671 hasRelatedWork W2906930031 @default.
• W2241130671 hasRelatedWork W2979750241 @default.
• W2241130671 hasRelatedWork W2979945030 @default.
• W2241130671 hasRelatedWork W2980241803 @default.
• W2241130671 hasRelatedWork W2980610961 @default.
• W2241130671 hasRelatedWork W3000909700 @default.
• W2241130671 hasRelatedWork W3190598388 @default.
• W2241130671 hasRelatedWork W921107325 @default.
• W2241130671 isParatext "false" @default.
• W2241130671 isRetracted "false" @default.
• W2241130671 magId "2241130671" @default.
• W2241130671 workType "article" @default.